$KALA
KALA BIO, Inc.

2020 Q3 Form 10-Q Financial Statement

#000155837020009714 Filed on August 06, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2020 Q2 2019 Q2
Revenue $2.220M $833.0K $2.057M
YoY Change 53.0% -59.5%
Cost Of Revenue $700.0K $760.0K $350.0K
YoY Change 4.48% 117.14%
Gross Profit $1.520M $70.00K $1.710M
YoY Change 94.87% -95.91%
Gross Profit Margin 68.47% 8.4% 83.13%
Selling, General & Admin $23.89M $15.30M $17.01M
YoY Change 56.37% -10.03% 137.86%
% of Gross Profit 1571.91% 21858.57% 994.56%
Research & Development $3.468M $6.053M $7.108M
YoY Change -50.95% -14.84% -3.55%
% of Gross Profit 228.16% 8647.14% 415.67%
Depreciation & Amortization $220.0K $220.0K $220.0K
YoY Change 0.0% 0.0% 144.44%
% of Gross Profit 14.47% 314.29% 12.87%
Operating Expenses $28.06M $22.11M $24.47M
YoY Change 21.91% -9.62% 68.51%
Operating Profit -$25.84M -$21.28M -$22.41M
YoY Change 19.82% -5.04%
Interest Expense $2.157M $2.134M $2.061M
YoY Change -1.06% 3.54% -2161.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$27.95M -$23.31M -$23.83M
YoY Change 20.58% -2.18% 63.0%
Income Tax
% Of Pretax Income
Net Earnings -$27.95M -$23.31M -$23.83M
YoY Change 20.59% -2.15% 62.96%
Net Earnings / Revenue -1258.92% -2798.56% -1158.24%
Basic Earnings Per Share
Diluted Earnings Per Share -$498.8K -$418.5K -$703.4K
COMMON SHARES
Basic Shares Outstanding 56.06M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q3 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $159.1M $184.6M $118.0M
YoY Change 63.01% 56.44% 29.39%
Cash & Equivalents $45.53M $128.0M $118.0M
Short-Term Investments $113.6M $56.50M
Other Short-Term Assets $4.000M $2.500M $900.0K
YoY Change 81.82% 177.78% 28.57%
Inventory $7.538M $5.700M $8.200M
Prepaid Expenses
Receivables $7.455M $4.281M $5.600M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $178.2M $197.0M $132.8M
YoY Change 58.36% 48.36% 44.5%
LONG-TERM ASSETS
Property, Plant & Equipment $2.822M $2.964M $33.40M
YoY Change -91.42% -91.13% 2126.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $15.80M $16.70M $12.60M
YoY Change 1.28% 32.54% 472.73%
Total Long-Term Assets $46.94M $48.49M $46.00M
YoY Change -3.22% 5.4% 1143.24%
TOTAL ASSETS
Total Short-Term Assets $178.2M $197.0M $132.8M
Total Long-Term Assets $46.94M $48.49M $46.00M
Total Assets $225.1M $245.5M $178.8M
YoY Change 39.81% 37.31% 87.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.222M $1.548M $3.200M
YoY Change 1.0% -51.63% 33.33%
Accrued Expenses $15.85M $13.97M $14.50M
YoY Change 0.32% -3.68% 173.58%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $19.55M $16.94M $17.70M
YoY Change 8.61% -4.29% 88.3%
LONG-TERM LIABILITIES
Long-Term Debt $71.97M $71.70M $70.70M
YoY Change 1.5% 1.41% 290.61%
Other Long-Term Liabilities $27.50M $27.90M $29.40M
YoY Change -5.17% -5.1%
Total Long-Term Liabilities $99.52M $99.63M $100.1M
YoY Change -0.38% -0.47% 453.04%
TOTAL LIABILITIES
Total Short-Term Liabilities $19.55M $16.94M $17.70M
Total Long-Term Liabilities $99.52M $99.63M $100.1M
Total Liabilities $119.1M $116.6M $117.7M
YoY Change 0.9% -0.96% 328.0%
SHAREHOLDERS EQUITY
Retained Earnings -$368.7M -$340.7M
YoY Change
Common Stock $56.00K $56.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $106.0M $128.9M $61.07M
YoY Change
Total Liabilities & Shareholders Equity $225.1M $245.5M $178.8M
YoY Change 39.81% 37.31% 87.03%

Cashflow Statement

Concept 2020 Q3 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income -$27.95M -$23.31M -$23.83M
YoY Change 20.59% -2.15% 62.96%
Depreciation, Depletion And Amortization $220.0K $220.0K $220.0K
YoY Change 0.0% 0.0% 144.44%
Cash From Operating Activities -$25.65M -$19.25M -$20.43M
YoY Change 11.96% -5.78% 121.82%
INVESTING ACTIVITIES
Capital Expenditures -$540.0K -$630.0K -$500.0K
YoY Change 157.14% 26.0% 177.78%
Acquisitions
YoY Change
Other Investing Activities -$57.05M -$56.54M
YoY Change
Cash From Investing Activities -$57.60M -$57.16M -$500.0K
YoY Change 27328.57% 11332.0% 177.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 750.0K 7.980M -10.00K
YoY Change -71.91% -79900.0% -120.0%
NET CHANGE
Cash From Operating Activities -25.65M -19.25M -20.43M
Cash From Investing Activities -57.60M -57.16M -500.0K
Cash From Financing Activities 750.0K 7.980M -10.00K
Net Change In Cash -82.50M -68.43M -20.94M
YoY Change 303.42% 226.79% 124.2%
FREE CASH FLOW
Cash From Operating Activities -$25.65M -$19.25M -$20.43M
Capital Expenditures -$540.0K -$630.0K -$500.0K
Free Cash Flow -$25.11M -$18.62M -$19.93M
YoY Change 10.62% -6.57% 120.71%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001479419
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2020Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q2 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2020Q2 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2020Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2020Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2020Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2020Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2020Q2 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2020Q2 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55831021
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36086254
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38150
dei Entity Registrant Name
EntityRegistrantName
KALA PHARMACEUTICALS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-0604595
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Address Address Line1
EntityAddressAddressLine1
490 Arsenal Way, Suite 120
dei Entity Address City Or Town
EntityAddressCityOrTown
Watertown
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02472
dei City Area Code
CityAreaCode
781
dei Local Phone Number
LocalPhoneNumber
996-5252
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
KALA
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
56059865
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
128023000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
85449000
CY2020Q2 us-gaap Short Term Investments
ShortTermInvestments
56536000
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4281000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11563000
CY2020Q2 us-gaap Inventory Net
InventoryNet
5711000
CY2019Q4 us-gaap Inventory Net
InventoryNet
4648000
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2473000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3824000
CY2020Q2 us-gaap Assets Current
AssetsCurrent
197024000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
105484000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2964000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2698000
CY2020Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
4109000
CY2019Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
3778000
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
28829000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
29781000
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
12584000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
12582000
CY2020Q2 us-gaap Assets
Assets
245510000
CY2019Q4 us-gaap Assets
Assets
154323000
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1548000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2518000
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13967000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20929000
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1425000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1327000
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
16940000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
24774000
CY2020Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
27930000
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
28673000
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
71697000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
71184000
CY2020Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
99627000
CY2019Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
99857000
CY2020Q2 us-gaap Liabilities
Liabilities
116567000
CY2019Q4 us-gaap Liabilities
Liabilities
124631000
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55831021
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36086254
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
56000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
36000
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
469627000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1904000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
325112000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-17000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-340723000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-295456000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
128943000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
29692000
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
245510000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
154323000
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
833000
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2057000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3443000
CY2020Q2 kala Product Revenue Cost
ProductRevenueCost
759000
CY2019Q2 kala Product Revenue Cost
ProductRevenueCost
352000
kala Product Revenue Cost
ProductRevenueCost
1113000
kala Product Revenue Cost
ProductRevenueCost
593000
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15301000
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
17007000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
30709000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
35243000
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6053000
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7108000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11487000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14067000
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
22113000
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
24467000
us-gaap Operating Expenses
OperatingExpenses
43309000
us-gaap Operating Expenses
OperatingExpenses
49903000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-21280000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-22410000
us-gaap Operating Income Loss
OperatingIncomeLoss
-41405000
us-gaap Operating Income Loss
OperatingIncomeLoss
-46460000
CY2020Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
102000
CY2019Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
646000
us-gaap Investment Income Interest
InvestmentIncomeInterest
400000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1402000
CY2020Q2 us-gaap Interest Expense
InterestExpense
2134000
CY2019Q2 us-gaap Interest Expense
InterestExpense
2061000
us-gaap Interest Expense
InterestExpense
4262000
us-gaap Interest Expense
InterestExpense
4155000
CY2020Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-2032000
CY2019Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1415000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-3862000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-2753000
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-23312000
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-23825000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-45267000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-49213000
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.42
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.70
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.94
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.45
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-45267000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-49213000
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
17000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
17000
CY2020Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
17000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
17000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
17000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
17000
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
55703882
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33882939
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
48232933
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33880494
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-23312000
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-23825000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23295000
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23825000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-45250000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-49213000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
82367000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2524000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-23825000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
61066000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
141510000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
772000
CY2020Q2 us-gaap Expense Related To Distribution Or Servicing And Underwriting Fees
ExpenseRelatedToDistributionOrServicingAndUnderwritingFees
500000
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7216000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2774000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-17000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-23312000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
128943000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
104978000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
39000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5262000
us-gaap Net Income Loss
NetIncomeLoss
-49213000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
61066000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
29692000
us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
400000
kala Stock Issued During Period Value New Issues At Market
StockIssuedDuringPeriodValueNewIssuesAtMarket
12546000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
938000
us-gaap Expense Related To Distribution Or Servicing And Underwriting Fees
ExpenseRelatedToDistributionOrServicingAndUnderwritingFees
8100000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
125423000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
270000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5358000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-17000
us-gaap Net Income Loss
NetIncomeLoss
-45267000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
128943000
us-gaap Profit Loss
ProfitLoss
-45267000
us-gaap Profit Loss
ProfitLoss
-49213000
us-gaap Depreciation
Depreciation
454000
kala Increase Decrease In Lease And Other Liabilities Noncurrent
IncreaseDecreaseInLeaseAndOtherLiabilitiesNoncurrent
-201000
us-gaap Depreciation
Depreciation
388000
kala Non Cash Operating Lease
NonCashOperatingLease
952000
kala Non Cash Operating Lease
NonCashOperatingLease
840000
kala Amortization Of Debt Discounts And Other Non Cash Interest
AmortizationOfDebtDiscountsAndOtherNonCashInterest
513000
kala Amortization Of Debt Discounts And Other Non Cash Interest
AmortizationOfDebtDiscountsAndOtherNonCashInterest
466000
us-gaap Share Based Compensation
ShareBasedCompensation
5271000
us-gaap Share Based Compensation
ShareBasedCompensation
5094000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-7282000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5648000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1351000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1106000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1306000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3955000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-973000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2249000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-6782000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1776000
kala Increase Decrease In Lease And Other Liabilities Noncurrent
IncreaseDecreaseInLeaseAndOtherLiabilitiesNoncurrent
-629000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-39134000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-51596000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
915000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
943000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
56535000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-57450000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-943000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
137969000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
16000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
20000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1207000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
39000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
139160000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
42576000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-52520000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
98031000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
183104000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
140607000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
130584000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
140607000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
130584000
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
12584000
CY2019Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
12578000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
128023000
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
118006000
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
136000
us-gaap Interest Paid Net
InterestPaidNet
3749000
us-gaap Interest Paid Net
InterestPaidNet
3683000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1852000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-340700000
CY2020Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2019Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
900000
CY2020Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
56553000
us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
17000
CY2020Q2 us-gaap Short Term Investments
ShortTermInvestments
56536000
CY2020Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
1025000
CY2019Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1387000
CY2020Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
4589000
CY2019Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
4166000
CY2020Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4206000
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2873000
CY2020Q2 kala Inventory Current And Noncurrent
InventoryCurrentAndNoncurrent
9820000
CY2019Q4 kala Inventory Current And Noncurrent
InventoryCurrentAndNoncurrent
8426000
CY2020Q2 us-gaap Inventory Net
InventoryNet
5700000
CY2020Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
4100000
CY2019Q4 us-gaap Inventory Net
InventoryNet
4600000
CY2019Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
3800000
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5347000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6502000
CY2020Q2 kala Accrued Revenue Reserves
AccruedRevenueReserves
5061000
CY2019Q4 kala Accrued Revenue Reserves
AccruedRevenueReserves
9482000
CY2020Q2 kala Development Costs Current
DevelopmentCostsCurrent
179000
CY2019Q4 kala Development Costs Current
DevelopmentCostsCurrent
1600000
CY2020Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
938000
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
760000
CY2020Q2 kala Accrued Commercialization Cost
AccruedCommercializationCost
800000
CY2019Q4 kala Accrued Commercialization Cost
AccruedCommercializationCost
930000
CY2020Q2 kala Accrued Contract Manufacturing
AccruedContractManufacturing
1462000
CY2019Q4 kala Accrued Contract Manufacturing
AccruedContractManufacturing
630000
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
180000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1025000
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13967000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20929000
CY2020Q2 kala Number Of Vehicles Leased
NumberOfVehiclesLeased
65
CY2020Q2 us-gaap Line Of Credit
LineOfCredit
500000
kala Vehicles Leased Term
VehiclesLeasedTerm
P3Y
kala Lessee Operating Lease Remaining Term Of Contract
LesseeOperatingLeaseRemainingTermOfContract
P1Y8M12D
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1185000
CY2019Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1187000
us-gaap Operating Lease Cost
OperatingLeaseCost
2371000
us-gaap Operating Lease Cost
OperatingLeaseCost
2243000
CY2020Q2 us-gaap Variable Lease Cost
VariableLeaseCost
658000
CY2019Q2 us-gaap Variable Lease Cost
VariableLeaseCost
383000
us-gaap Variable Lease Cost
VariableLeaseCost
1068000
us-gaap Variable Lease Cost
VariableLeaseCost
507000
CY2020Q2 us-gaap Lease Cost
LeaseCost
1843000
CY2019Q2 us-gaap Lease Cost
LeaseCost
1570000
us-gaap Lease Cost
LeaseCost
3439000
us-gaap Lease Cost
LeaseCost
2750000
CY2020Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
1686000
CY2019Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
911000
us-gaap Operating Lease Payments
OperatingLeasePayments
3130000
us-gaap Operating Lease Payments
OperatingLeasePayments
1654000
CY2019Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.1163
CY2020Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.1163
kala Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
248505
CY2019 kala Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
297988
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.80
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.81
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.61
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.82
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0042
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0173
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0187
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0258
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.35
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.71
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.88
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.71
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
957097
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
11.70
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2493000
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2621000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4988000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5094000
CY2020Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
11674251
CY2019Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
8488405
CY2019Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2019Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2020Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0

Files In Submission

Name View Source Status
0001558370-20-009714-index-headers.html Edgar Link pending
0001558370-20-009714-index.html Edgar Link pending
0001558370-20-009714.txt Edgar Link pending
R60.htm Edgar Link pending
0001558370-20-009714-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
kala-20200630.xsd Edgar Link pending
kala-20200630x10q.htm Edgar Link pending
kala-20200630x10q_htm.xml Edgar Link completed
kala-20200630xex10d2.htm Edgar Link pending
kala-20200630xex10d3.htm Edgar Link pending
kala-20200630xex31d1.htm Edgar Link pending
kala-20200630xex31d2.htm Edgar Link pending
kala-20200630xex32d1.htm Edgar Link pending
kala-20200630xex32d2.htm Edgar Link pending
kala-20200630_cal.xml Edgar Link unprocessable
kala-20200630_def.xml Edgar Link unprocessable
kala-20200630_lab.xml Edgar Link unprocessable
kala-20200630_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending